Effects of intravenous etidronate and oral corticosteroids in fibrodysplasia ossificans progressiva

Clinical Orthopaedics and Related Research

Volumn 346, Issue , 1998, Pages 117-120

  Brantus, Jean François ^a   Meunier, Pierre J ^a  

^a EDOUARD HERRIOT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN; CORTICOSTEROID; ETIDRONIC ACID;

ADOLESCENT; ADULT; ARTHRITIS; BONE MINERALIZATION; CELL SWELLING; CHILD; CLINICAL ARTICLE; CONFERENCE PAPER; EARLY DIAGNOSIS; FEMALE; FOLLOW UP; HUMAN; INFLAMMATION; INTRAVENOUS DRUG ADMINISTRATION; JOINT MOBILITY; MALE; ORAL DRUG ADMINISTRATION; OSSIFYING MYOSITIS; PRIORITY JOURNAL; TREATMENT PLANNING;

EID: 0031964092     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1097/00003086-199801000-00017     Document Type: Conference Paper

References (24)

1. Bassett CA, Donath A, Macagno F, et al: Diphosphonates in the treatment of myositis ossificans. Lancet 2:845, 1969.
2. Bruni L, Giammaria P, Tozzi MC: Fibrodysplasia ossificans progressiva. An 11-year-old boy treated with a diphosphonate. Acta Paediatr Scand 79:994-998, 1990.
3. Caron KH, Dipietro MA, Aisen AM, et al: MR imaging of early fibrodysplasia ossificans progressiva. J Comput Assist Tomogr 14:318-321, 1990.
4. Cohen RB, Hahn GV, Tabas JA, et al: The natural history of heterotopic ossification in patients who have fibrodysplasia ossificans progressiva. J Bone Joint Surg 75A:215-219,1993.
5. Connor JM, Evans DA: Genetic aspects of fibrodysplasia ossificans progressiva. J Med Genet 19:35-39, 1982.
6. Connor JM, Evans DA: Fibrodysplasia ossificans progressiva. The clinical features and natural history of 34 patients. J Bone Joint Surg 64B:76-83, 1984.
7. Cremin B, Connor JM, Beighton P: The radiological spectrum of fibrodysplasia ossificans progressiva. Clin Radiol 33:499-508, 1982.
8. Crofford LJ, Brahim JS, Zasloff MA, et al: Failure of surgery and isotretinoin to relieve jaw immobilization in fibrodysplasia ossificans progressiva: Report of two cases. J Oral Maxillofac Surg 48:204-208, 1990.
9. Dixon TF, Mulligan L, Nassim R, Stevenson FH: Myositis ossificans progressiva. J Bone Joint Surg 36B:445-449, 1954.
10. Fang MA, Reinig JW, Hill SC, et al: Technetium-99m MDP demonstration of heterotopic ossification in fibrodysplasia ossificans progressiva. Clin Nucl Med 11:8-9, 1986.
11. Guze BH, Schelbert H: The nuclear medicine bone image and myositis ossificans progressiva. Clin Nucl Med 14:161-162, 1989.
12. Heidelberg KP, Dipietro M: Fibrodysplasia ossificans progressiva. Pediatr Pathol 7:105-109, 1987.
13. Hentzer B, Jacobsen HH, Asboe-Hansen G: Fibrodysplasia (myositis) ossificans progressiva treated with disodium etidronate. Clin Radiol 29:69-75, 1978.
14. Holmsen H, Ljunghall S, Hierton T: Myositis ossificans progressiva. Clinical and metabolical observations in a case treated with diphosphonate (EHDP) and surgical removal of ectopic bone. Acta Orthop Scand 50:33-38, 1979.
15. Illingworth RS: Myositis ossificans progressiva (Munchmeyer's disease). Brief review with report of two cases treated with corticosteroids and observed for 16 years. Arch Dis Child 46:264-268, 1971.
16. Maxwell WA, Spicer SS, Miller RL, et al: Histochemical and ultrastructural studies in fibrodysplasia ossificans progressiva (myositis ossificans progressiva). Am J Pathol 87:483-498, 1977.
17. Meunier PJ, Chapuy MC, Delmas P, et al: Intravenous disodium etidronate therapy in Paget's disease of bone and hypercalcemia of malignancy. Am J Med 82:71-78, 1987.
18. Rogers JG, Dorst JP, Geho WB: Use and complications of high-dose disodium etidronate therapy in fibrodysplasia ossificans progressiva. J Pediatr 91:1011-1014, 1977.
19. Rogers JG, Geho WB: Fibrodysplasia ossificans progressiva. A survey of forty-two cases. J Bone Joint Surg 61A:909-914, 1979.
20. Russell RG, Smith R, Bishop MC, Price PA: Treatment of myositis ossificans progressiva with a diphosphonate. Lancet 1:10-11, 1972.
21. Shafritz AB, Shore EM, Gannon FH, et al: Overexpression of an osteogenic morphogen in fibrodysplasia ossificans progressiva. N Engl J Med 335:555-561, 1996.
22. Smith R, Athanasou NA, Vipond SE: Fibrodysplasia (myositis) ossificans progressiva. Clinicopathological features and natural history. Q J Med 89:445-456, 1996.
23. Smith R, Russell RGG, Woods CG: Clinical features of eight patients and their response to treatment. J Bone Joint Surg 58B:48-57, 1976.
24. Wood BJ, Robinson GC: Drug induced bone changes in myositis ossificans progressiva. Pediatr Radiol 5:40-43, 1976.